PDL BioPharma, Inc. (PDLI)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
2.86+0.12 (+4.38%)
At close: 4:00 PM EDT
People also watch:
MYGNINCYVRTXENZNALKS
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open2.73
Prev Close2.74
Bid2.87 x 1000
Ask2.95 x 500
Day's Range2.71 - 2.88
52wk Range2.58 - 5.68
1y Target EstN/A
Market Cap473.45M
P/E Ratio (ttm)2.03
Beta0.77
Volume1,570,129
Avg Vol (3m)1,399,709
Dividend & Yield0.20 (7.30%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube5 days ago

    ETF’s with exposure to PDL BioPharma, Inc. : August 22, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to PDL BioPharma, Inc. Here are 5 ETF’s with the largest exposure to PDLI-US. Comparing the performance and risk of PDL BioPharma, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • 3 Horrible Stocks for Retirees
    Motley Fool12 days ago

    3 Horrible Stocks for Retirees

    These three stocks offer temping dividend yields, but I think they should be avoided.

  • PDL BioPharma, Inc. :PDLI-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016
    Capital Cube17 days ago

    PDL BioPharma, Inc. :PDLI-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016

    Categories: Yahoo Finance Click here to see latest analysis PDL BioPharma, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of PDL BioPharma, Inc. – Compugen Ltd., Nektar Therapeutics, Eli Lilly and Company, Amgen Inc. and Sangamo BioSciences, Inc. (CGEN-US, NKTR-US, LLY-US, AMGN-US and SGMO-US) that have ... Read more (Read more...)